HEPATITIS C 2022 National Summary Report June 2022 State of Medicaid Access

Posted 10/25/2022 (updated 3/27/2024)

Hepatitis C: State of Medicaid Access is a collaboration between the Center for Health Law and Policy Innovation of Harvard Law School (CHLPI) and the National Viral Hepatitis Roundtable (NVHR). The project evaluates hepatitis C (HCV) treatment restriction policies across state Medicaid programs, including all 50 states, the District of Columbia, and Puerto Rico (referred to in this report as “states”). The goal of this project is to encourage states and empower advocates to work toward improved access to curative HCV treatment across all Medicaid programs, in order to ensure that every Medicaid enrollee who can benefit from this treatment is able to access it.